Civic Intelligence

Answer Als

990 • Fiscal year 2020 • EIN 47-1643994

Jan 01, 2020 to Dec 31, 2020

New Orleans, LA
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

12th percentile

0.00x

Higher debt load relative to assets than 12% of similar nonprofits.

2020 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2020

Liabilities / Revenue

11th percentile

0.01x

Higher debt load relative to revenue than 11% of similar nonprofits.

2020 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2020

Net Margin

78th percentile

23%

Higher net margin than 78% of similar nonprofits.

2020 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2020

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2020

Asset Growth

34th percentile

1.4%

Faster asset growth than 34% of similar nonprofits.

2020 filings • 501(c)3 • $5M-$10M nonprofits • Annualized from 2019 to 2020

Revenue Growth

91st percentile

67%

Faster revenue growth than 91% of similar nonprofits.

2020 filings • 501(c)3 • $5M-$10M nonprofits • Annualized from 2019 to 2020

Assets

Up

$8,316,048

Up $113,665 (+1.4%) from 2019

Net Assets

Up

$8,296,549

Up $529,123 (+6.8%) from 2019

Liabilities

Down

$19,499

Down $415,458 (-96%) from 2019

Revenue

Up

$2,276,502

Up $915,913 (+67%) from 2019

Expenses

Down

$1,747,379

Down $589,260 (-25%) from 2019

Net Income

Up

$529,123

Up $1,505,173 (+154%) from 2019

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$10M$5.0M$0Assets 2015: $280,264Liabilities 2015: $0Net Assets 2015: $280,2642015Assets 2016: $1,151,283Liabilities 2016: $0Net Assets 2016: $1,151,2832016Assets 2017: $2,069,660Liabilities 2017: $75,284Net Assets 2017: $1,994,3762017Assets 2018: $9,195,404Liabilities 2018: $451,928Net Assets 2018: $8,743,4762018Assets 2019: $8,202,383Liabilities 2019: $434,957Net Assets 2019: $7,767,4262019Assets 2020: $8,316,048Liabilities 2020: $19,499Net Assets 2020: $8,296,5492020Assets 2021: $7,757,258Liabilities 2021: $131,415Net Assets 2021: $7,625,8432021Assets 2022: $6,354,337Liabilities 2022: $31,220Net Assets 2022: $6,323,1172022Assets 2024: $7,362,169Liabilities 2024: $464,664Net Assets 2024: $6,897,5052024

Highlighted filing

2020

Assets$8,316,048
Liabilities$19,499
Net Assets$8,296,549

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$10M$5.0M$0-$5.0MRevenue 2015: $438,943Expenses 2015: $158,679Net Income 2015: $280,2642015Revenue 2016: $1,142,342Expenses 2016: $271,323Net Income 2016: $871,0192016Revenue 2017: $2,166,797Expenses 2017: $1,826,704Net Income 2017: $340,0932017Revenue 2018: $8,405,871Expenses 2018: $1,656,771Net Income 2018: $6,749,1002018Revenue 2019: $1,360,589Expenses 2019: $2,336,639Net Income 2019: -$976,0502019Revenue 2020: $2,276,502Expenses 2020: $1,747,379Net Income 2020: $529,1232020Revenue 2021: $1,800,662Expenses 2021: $2,468,582Net Income 2021: -$667,9202021Revenue 2022: -$12,049Expenses 2022: $1,225,402Net Income 2022: -$1,237,4512022Revenue 2024: $2,817,907Expenses 2024: $3,245,884Net Income 2024: -$427,9772024

Highlighted filing

2020

Revenue$2,276,502
Expenses$1,747,379
Net Income$529,123
Filing Detail Status

This 2020 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2020 to Dec 31, 2020
Mission and Program Overview

Mission

To find solutions for people living with als now and for the future by utilizing knowledge of patients, leading researchers and technology to seek immediate solutions to improve the lives of those living with als until a treatment or cure is found; discover what causes als; develop models to understand als and screen for drug and cellular therapy; discover therapies that could substantially slow or halt the progress of als and ultimately cure the disease; provide all gathered information free for worldwide use by clinicians, scientists and pharma to rapidly advance therapeutics.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Peer Organizations

Similar nonprofits based on the same Siviq industry and scale cohort. 2020 filings • 501(c)3 • $5M-$10M nonprofits